Literature DB >> 15081620

Frequencies of epitope-specific cytotoxic T lymphocytes in active chronic viral hepatitis B infection by using MHC class I peptide tetramers.

Yuzhang Wu1, Jingbo Zhang, Shiyuan Chen, An Chen, Li Wang, Jingyi Li, Tingting Zhao, Liyun Zou, Yan Tang, L Tingrong, Fang Wang.   

Abstract

Hepatitis B virus (HBV)-specific cytotoxic T lymphocytes (CTLs) are thought to play key roles in viral control and liver damage. We have used HLA-A*02 tetramer complex to human HBV core 18-27 (Tc 18-27), envelope 183-191 (Te 183-191), envelope 335-343 (Te 335-343), and polymerase 575-583 (Tp 575-583) epitopes to characterize HLA class I-restricted CD8+ T cells in active chronic HBV infection. The frequencies of specific epitopes circulating tetramer+ cells were determined in whole-blood samples by analysis of flow cytometry. The correlation of HBV epitope-specific CTL, between viral replication and liver damage, was analyzed by multiple regression. Our data shown that HBV-specific CD8+ T cells can be easily detected in peripheral blood of active chronic HBV infections. No significant correlation was found between either the frequency of HBV-specific CD8+ T cells and the viral load, or the frequency of HBV-specific CD8+ T cells and the levels of alanine transaminase. These results suggest that the existence of epitope-specific HBV CTLs are not directly correlated to hepatocyte injury, and the frequencies of HBV-specific T cells are not determinant of immune-mediated protection in chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081620     DOI: 10.1016/j.imlet.2004.01.002

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

1.  Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen.

Authors:  Wei Zhang; Sheng-Fu Dong; Shu-Hui Sun; Yuan Wang; Guang-Di Li; Di Qu
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

2.  Antigen-specific immune responses to influenza vaccine in utero.

Authors:  Deepa Rastogi; Chaodong Wang; Xia Mao; Cynthia Lendor; Paul B Rothman; Rachel L Miller
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

3.  Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2011-06-14       Impact factor: 6.047

4.  Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B.

Authors:  Corinna Jen-Hui Pan; Hui-Lin Wu; Stephanie Fang-Tzu Kuo; Jia-Horng Kao; Tai-Chung Tseng; Chen-Hua Liu; Pei-Jer Chen; Chun-Jen Liu; Ding-Shinn Chen
Journal:  Hepatol Int       Date:  2011-07-16       Impact factor: 6.047

5.  H-2 Kd-restricted hepatitis B virus-derived epitope whose specific CD8+ T lymphocytes can produce gamma interferon without cytotoxicity.

Authors:  An Chen; Li Wang; Jingbo Zhang; Liyun Zou; Zhengcai Jia; Wei Zhou; Ying Wan; Yuzhang Wu
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Antigen-specific CD4+ T cells recognize epitopes of protective antigen following vaccination with an anthrax vaccine.

Authors:  Elsa M Laughlin; Joseph D Miller; Eddie James; Dimitri Fillos; Chris C Ibegbu; Robert S Mittler; Rama Akondy; William Kwok; Rafi Ahmed; Gerald Nepom
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

7.  Restoration of HBV-specific CD8+ T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy.

Authors:  Dongyao Wang; Binqing Fu; Xiaokun Shen; Chuang Guo; Yanyan Liu; Junfei Zhang; Rui Sun; Ying Ye; Jiabin Li; Zhigang Tian; Haiming Wei
Journal:  Signal Transduct Target Ther       Date:  2021-11-05

Review 8.  A Systematic Review of T Cell Epitopes Defined from the Proteome of Hepatitis B Virus.

Authors:  Yandan Wu; Yan Ding; Chuanlai Shen
Journal:  Vaccines (Basel)       Date:  2022-02-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.